Skip to main content

SPRAY-CB: A Sham controlled prospective randomized trial of the RejuvenAir system for the treatment of moderate to severe chronic obstructive pulmonary disease with chronic bronchitis

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

CSA Medical, Inc.

Start Date

April 13, 2020

End Date

July 31, 2024
 

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

CSA Medical, Inc.

Start Date

April 13, 2020

End Date

July 31, 2024